It’s just a guess but it’s more useful to Advent than it is to us as they will be using it…..second hand equipment ain’t worth much….and if the transfer price is generous enough for Advent to repay the capital outlay overtime for the equipment then management could claim all shareholder investment has been repaid. It’s easy to do when the transfer price is not disclosed between NWBO and Advent (for understandable reasons) and you have a longterm contract and a licence to make vaccines….it’s a sure thing….
Market Data 
Markets 
AI
